tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher James, 24 are a BUY (88.89%), 2 are a HOLD (7.41%), 1 are a SELL (3.7%).
Analyst Christopher James, carries an average stock price target met ratio of 72.73% that have a potential upside of 56.02% achieved within 679 days. Previously, Christopher James worked at LADENBURG, B. RILEY.
Christopher James’s has documented 50 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 21-Sep-2017.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 7/18/2017. The price target of $20 was fulfilled within 79 days with a profit of $7.59 (61.16%) receiving and performance score of 7.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$1.82 (1011.11%)
$5
6 years 7 months 10 days ago
(03-May-2019)
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold
$4
7 years 10 months 5 days ago
(08-Feb-2018)
4/4 (100%)
$-0.81 (-16.84%)
106
Buy
$5
$4.82 (2677.78%)
$6
8 years 2 days ago
(11-Dec-2017)
0/4 (0%)
$2.14 (74.83%)
Buy
$10
8 years 3 months 1 days ago
(12-Sep-2017)
0/2 (0%)
$5.79 (137.53%)
Hold
$4
$3.82 (2122.22%)
$5
8 years 3 months 2 days ago
(11-Sep-2017)
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Christopher James?
